Navigation Links
Lung Disease Tied to Increased Risk for Cardiac Events
Date:12/5/2008

IPF patients 3 times more likely to suffer heart problems, study says

FRIDAY, Dec. 5 (HealthDay News) -- People with the deadly lung disease idiopathic pulmonary fibrosis (IPF) are three times more likely than people without the disease to suffer severe cardiac events such as a heart attack, according to a British study.

"If you look at them over time, people with IPF have roughly a threefold increased risk of acute coronary syndrome, which is a greater increase than you get from smoking," lead author Dr. Richard B. Hubbard, a professor of epidemiology at the University of Nottingham, said in an American Thoracic Society news release.

Hubbard and his colleagues analyzed data from 920 IPF patients and 3,593 people without the disease. In addition to being at increased risk for heart attacks, IPF patients were 23 percent more likely to have angina, 60 percent more likely to have a stroke, and three times more likely to develop deep vein thrombosis.

The researchers also found that IPF patients were more than twice as likely to have been prescribed amiodarone, a medication used to treat irregular heartbeats. The drug has been implicated as a cause of fibrotic lung disease, the researchers said.

The study was published in the second issue for December of the American Journal of Respiratory and Critical Care Medicine.

About 60,000 people in the United States have IPF, and 21,000 new cases are diagnosed each year. Median survival from the time of diagnosis is about three years. Currently, there are no treatments known to increase survival. Medical knowledge about IPF is limited.

"We know that genetic factors play some role in IPF, because it clusters in families in about 10 percent of cases, and in a similar number of people, there is evidence that environmental factors, such as exposure to metal dust at work and cigarette smoking may have a role," Hubbard said. "But studies from the U.S.A. and U.K. suggest that IPF is becoming more common, and the reasons for this are unclear."

In an accompanying editorial, Dr. David Zisman and Dr. Steven Kawut said further research is needed "to better understand the relationship between IPF and systemic vascular disease as well as the mechanisms shared by the two syndromes."

If studies confirm a causal relationship, "the presence of IPF itself could constitute a sufficiently potent risk factor for coronary artery disease such that more aggressive goals in risk factor modification would be warranted."

More information

The U.S. National Heart, Lung, and Blood Institute has more about IPF.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, Dec. 5, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Double threat: Deadly lung disease also linked to heart attacks
2. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
3. Researchers identify cell group key to Lyme disease arthritis
4. Study shows school-based program enables children and adolescents to better manage chronic disease
5. CA$2.4 million toward gene therapy for human degenerative retinal diseases
6. Diagnosis and Drug Treatment of Alzheimers Disease in China is Low and Will Remain Low Through 2012
7. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
8. Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease
9. Large study illustrates cardiac CT can effectively assess coronary artery disease
10. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
11. Nine Year Ban Fails to Eradicate Asbestos Related Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lung Disease Tied to Increased Risk for Cardiac Events
(Date:5/24/2016)... Linda, CA (PRWEB) , ... May 24, 2016 ... ... fluorescent cell imaging; high content imaging; multiplex immunoassays are widely used for cell ... important for labs to maximize their quality and efficiency in these areas. , ...
(Date:5/23/2016)... ... 23, 2016 , ... On the occasion of his 25th Anniversary of changing ... loss process: , New patients have a consultation and evaluation (done by Dr. Ferdico ... , Body Composition Analysis, There are 15 things that each patient gets checked for, ...
(Date:5/23/2016)... ... 23, 2016 , ... According to an article published May 11th ... birth of her son, Rockwell Lloyd Liu, and notes that gestational surrogacy helped make ... Bill” star explains that, as a career oriented single woman, gestational surrogacy made parenthood ...
(Date:5/23/2016)... ... May 23, 2016 , ... NYDNRehab, a New York City-based ... athletes. This is the first time this type of technology, which was developed by ... to the public in New York. , With over 10 million sport injuries ...
(Date:5/23/2016)... ... May 23, 2016 , ... California State University Northridge ... quality of life and is currently focusing on ways to improve how people ... tested through research to find out whether watching them could have a significant ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... SAN FRANCISCO, Calif. , May 19, 2016 /PRNewswire/ ... a biopharmaceutical company developing novel therapeutics for the treatment ... announced that new GBT440 data will be presented in ... 21 st Congress in Copenhagen ... ongoing Phase 1/2 GBT440-001 study in sickle cell disease ...
(Date:5/19/2016)... 2016 BioLineRx Ltd. (NASDAQ/TASE: BLRX) ... treatment of multiple cancer and hematological indications, will be ... abstract titled " Clinical response in relapsed/refractory AML patients ... BL-8040, a potent CXCR4 antagonist; results of a Phase ... at the European Hematology Association 21st Congress, to be ...
(Date:5/19/2016)... CAMBRIDGE, Massachusetts , May 19, 2016 ... pharmaceuticals and diagnostics based on the gut microbiome, is pleased ... Cambridge, MA to support its operations ... office is located at Kendall Square, the heart of ... global hub for transforming scientific insights into new drugs. The ...
Breaking Medicine Technology: